Apsen Farmaceutica S.A.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Sao Paulo Brazil (1969)
Status: No NME R&D (1969)

Organization Overview

First Clinical Trial
2011
NCT01203371
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Apsen Farmaceutica S.A.